Summary of the Aesthetic Medicine Industry Conference Call Industry Overview - The aesthetic medicine industry is projected to see a revenue growth of 7% year-on-year in early 2024, with a customer traffic increase of approximately 10%, although the average transaction price is expected to decline by 3%-4% [2][3][21]. - Non-surgical light aesthetic projects account for 70% of the market, with photonic skin treatments making up 45% and non-invasive injection types 25% [2][5]. Key Insights and Arguments - **Product Performance**: - Recombinant collagen products, such as the Jingbo Weimei series, showed significant growth, with a 109% increase in January and an expected 60% in February [2][6]. - New products in the "童颜水光" (youthful water light) category and composite kinetic products also demonstrated strong growth [2][6]. - **Pricing Trends**: - Sales of the Weimei series are increasing, but prices are declining, particularly for the 4 mg model, which has seen a price drop of 30% [2][6]. - The average price decline is attributed to bundled sales strategies, leading to a 20%-30% decrease in average transaction prices [6][7]. - **OEM Collaboration**: - The rise of OEM collaboration is noted, with the group partnering with Jingbo to customize 8 mg products, reducing procurement costs and allowing flexible pricing strategies [2][8]. - The procurement cost for customized products is approximately 700 to 800 yuan, with a retail price set between 8,800 and 8,900 yuan [7][8]. - **Market Dynamics**: - The market is seeing a shift with pharmaceutical companies entering the aesthetic medicine field, leveraging their R&D and branding advantages, but facing challenges in adapting to the fast-changing market and consumer needs [4][15][16]. Additional Important Insights - **Consumer Behavior**: - Customer traffic during the Spring Festival showed a significant increase, particularly in first-tier cities, with some hospitals reporting appointment rates reaching 100% post-holiday [3][4]. - **Product Innovations**: - New products in the youthful water light category are being introduced with lower concentrations to make them more affordable, thus expanding the consumer base [9][10]. - **Future Trends**: - The aesthetic medicine industry is expected to maintain a growth rate of 8%-10% in 2026, driven by the introduction of new technologies and products, despite ongoing regulatory scrutiny [21]. - **Sales Team Effectiveness**: - Companies like Jinbo have developed strong sales teams that maintain good relationships with institutions and media, enhancing their competitive edge [17]. - **Emerging Products**: - The introduction of PDRN materials is anticipated to create a market potential of around 5 billion yuan, with several companies, including Lepu, working towards obtaining necessary certifications [20][21]. This summary encapsulates the key points discussed in the conference call regarding the aesthetic medicine industry, highlighting growth trends, pricing strategies, and market dynamics.

摘要 春节期间高端酒店和旅游需求超预期，出行相关消费显著受益，酒店 RevPAR 大幅提升，如华住、锦江、首旅等头部酒店集团均实现显著增 长，价格贡献是主要驱动力。 餐饮行业持续升温，全国重点零售和餐饮企业日均销售额同比增长 8.6%，火锅龙头企业翻台率和接待量均有所增加，预定量显著提升，表 明外出就餐比例增加带动餐饮业增长。 免税板块总体符合预期，但海南地区三亚增速优于海口，表明区域市场 存在差异。政府消费券有效拉动海南离岛免税增长，预计全年海南离岛 免税销售增速将维持在 20%左右。 珠宝零售市场分化，高端奢侈品珠宝消费较好，但金价高位对投资金需 求未直接拉动，首饰消费需求集中释放。部分品牌如潮宏基、周大福等 在高金价背景下表现强劲。 医美领域客流双位数增长，但单价有所下降。重组胶原蛋白类产品增速 亮眼，童颜水光类产品通过走量模式销售。预计 2026 年医美行业将比 2025 年更乐观，新技术与新成分加快获批。 春节消费观察总结 20260223 Q&A 今年春节期间消费市场的整体表现如何？有哪些主要趋势？ 今年春节期间，消费市场表现出三大主要趋势。首先，高端消费复苏明显，且 呈现 K 型分化。例如，大众 ...

Core Insights - The Chinese medical beauty market is experiencing a significant transformation in 2025, marked by a notable divergence in the performance of various brands within the regenerative filling materials sector, with "Zhenai Su Fei" leading with a 463% growth while "Yiyan Shi" saw a 56% decline [1][2] - The market is witnessing a "Matthew Effect," where leading brands are consolidating their positions, while smaller brands struggle to survive [1][10] Regenerative Filling Materials - Regenerative filling materials have become the "MVP" of the year, with a 93.40% increase in sales in 2025, continuing a three-year growth trend [2] - "Zhenai Su Fei" from Aimeike achieved the highest growth rate at 463%, while "Yiyan Shi" faced a significant decline of 56% [2][3] - The performance of "Yiyan Shi" is attributed to its early market entry, but its novelty has worn off, leading to decreased consumer interest [3] Market Dynamics - The market is increasingly competitive, with new brands and materials entering, but consumers tend to prefer established brands for their reliability [4] - The sales of the once-popular ultrasonic device have dropped significantly, with a 55.2% decline in 2025, as consumers are opting for newer products and are more budget-conscious [4][5] Equipment and Technology - The "Meila Meisu" ultrasonic knife has emerged as a leading anti-aging device, with a 147.22% increase in sales, appealing to users over 35 seeking non-invasive treatments [4][5] - The ultrasonic device is transitioning from a "market dividend period" to a "technical barrier period," indicating a shift in competitive dynamics [5][7] Hyaluronic Acid - Hyaluronic acid remains a top-selling product, with a 19.70% increase in sales in 2025, maintaining its status as a staple in the market [8] - Despite its growth, hyaluronic acid faces challenges such as market oversupply and price wars, which could weaken its position in the long term [8][9] Future Growth Areas - The market is shifting towards specialized treatments, with a focus on individual needs and the emergence of new segments like collagen reorganization and hair loss treatment, which are expected to see significant growth [10][11] - The collagen reorganization market is projected to grow at a compound annual growth rate of 41.4% from 2023 to 2027, indicating strong potential [10]

Group 1 - The core point of the article is that the company Aimeike reported that as of February 10, 2026, the number of its shareholders reached 61,417 [2]

医美终端春节跟踪要点小结 # 要点总结：医美终端景气度稳健上升符合预期，当前复苏趋势已初步显现，后续3月大促有望成为进一步验证β 观测周期，重点跟踪终端复苏延续性、高端老客消费改善持续性及核心新品放量表现。 1-2月整体景气度 ✔1月营收同比+11%，客流同比+15%； ✔2月营收预计同比-3%~-4%，客流预计-8%~-9%。 ✔# 1–2月合计营收 医美终端春节跟踪要点小结 # 要点总结：医美终端景气度稳健上升符合预期，当前复苏趋势已初步显现，后续3月大促有望成为进一步验证β 观测周期，重点跟踪终端复苏延续性、高端老客消费改善持续性及核心新品放量表现。 1-2月整体景气度 ✔1月营收同比+11%，客流同比+15%； ✔2月营收预计同比-3%~-4%，客流预计-8%~-9%。 区域＆客群＆业态分化 ✔区域分化：# 一线及新一线城市节后预约回升更快，假期缩短至3–5天（较往年少2–3天）；二三线城市放假6–7 天，部分三线城市至2月24–25日才恢复营业。 ✔客群结构：# 春节以中高端老客为主，年消费5–10万客群占比最高。 1–2月客流结构：年消费2–5万约10%、5–8万约40%、8–10万约30%、10 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights a steady recovery in consumer spending during the Spring Festival, with significant increases in payment transactions and retail sales compared to the previous year [4][26] - The report emphasizes the importance of high-quality companies in high-growth sectors driven by emotional consumption themes [7][35] Summary by Sections Industry Dynamics - The Spring Festival saw a robust recovery in social consumption, with payment transactions on New Year's Eve reaching 4.931 billion, a 21.64% increase from the previous year [4][26] - Key regions like Hainan and cities such as Tianjin and Zhenjiang showed strong performance in retail and dining, with Hainan's duty-free shopping amounting to 1.03 billion yuan, up 20.9% year-on-year [4][27] - Domestic travel orders surged by 60%, and outbound travel orders increased by over 180% during the holiday period [4][26] Investment Recommendations - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending companies like Laopai Gold and Chaohongji for their differentiated product offerings [7][35] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, with recommendations for Yonghui Supermarket and Aiyingshi [7][35] - Investment Theme 3: Highlight domestic beauty brands that cater to emotional value and innovative safe ingredients, recommending brands like Maogeping and Proya [7][35] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending companies like Meilitiantian Medical Health and Aimeike [7][35] Market Performance - The retail and social service indices reported declines of 1.59% and 0.78% respectively during the week from February 9 to February 13, 2026 [6][15] - The report notes that the education sector saw the highest growth among sub-sectors, while the watch and jewelry sector led the year-to-date performance with an 11.29% increase [6][18] Company Highlights - Laopai Gold reported a significant revenue increase of 250.9% in the first half of FY2025, driven by strong consumer demand and brand expansion [37] - Chaohongji is expected to achieve a net profit growth of 125% to 175% in FY2025, supported by its differentiated product strategy [37] - Maogeping and Proya are highlighted for their strong performance in the beauty sector, with Maogeping achieving a revenue increase of 31.3% in FY2025 [37]

Group 1 - The year 2025 saw significant commercial events that reflect changing consumer expectations and corporate accountability [2] - Companies faced backlash for safety and quality issues, highlighting the need for improved internal processes and transparency [3][4][8][10][11][12][19] - The shift in consumer power emphasizes the importance of brands respecting public sentiment and adapting to a more transparent market environment [21][22] Group 2 - 吉祥航空 faced criticism for distributing expired snacks, revealing serious lapses in food safety protocols and poor crisis management [3][4] - 千禾's "zero-additive" soy sauce controversy raised questions about product labeling and consumer trust, leading to a re-evaluation of marketing strategies [5][6][7] - The charging battery industry experienced a safety crisis with 罗马仕 recalling over 490,000 units due to fire risks, contrasting with 安克创新's swift response [8][9] - 白象's "half bag" noodle marketing was criticized for misleading consumers about product quantity, resulting in a rebranding effort [9][10] - 华熙生物 and 巨子生物 engaged in a public dispute over product claims, damaging both brands' reputations in the competitive beauty market [10][11] - 爱康国宾 faced a public relations disaster after a client revealed a serious misdiagnosis, leading to widespread criticism of the commercial health screening industry [11][12] - 理想汽车's marketing stunt involving a crash test video backfired, leading to public skepticism and a necessary apology [12][13][14] - 桃李面包's controversial advertising campaign resulted in a public backlash, but the company's transparent response turned the situation into a positive PR opportunity [15][16] - 西贝's struggle with public perception regarding the use of pre-prepared ingredients led to significant operational changes and store closures [17][18] - 始祖鸟's environmentally insensitive marketing stunt sparked outrage among its core audience, prompting a public apology and highlighting the importance of brand values [19][20]

Core Viewpoint - The recovery of high-end consumption in China is accelerating, driven primarily by the wealth effect of high-net-worth individuals and policy stimuli targeting the middle class [1] Group 1: Duty-Free Industry - The duty-free sector is expected to benefit significantly from the recovery of high-end consumption, with a low base and strong policy incentives driving growth [2] - The launch of the Hainan Free Trade Port is anticipated to have a substantial impact on local and national duty-free businesses, with a continued trend of high-end consumption recovery [2] - China Duty Free Group is expected to see sustained performance growth, driven by both domestic demand recovery and the untapped potential of inbound tourist spending [2] Group 2: Gold and Jewelry - Rising gold prices are favorable for high-end self-consumption and brand transformation, with consumers increasingly valuing emotional connections over mere functionality [3] - The trend of store adjustments is expected to continue, with companies that expand their channels by 2026 likely to see greater performance elasticity [3] - Companies like Lao Pu Gold and Chao Hong Ji are expected to perform well due to strategic store optimization and product offerings [3] Group 3: Baijiu Industry - The baijiu industry is showing signs of recovery, with strong demand for premium products like Moutai, which has seen prices rise above 1,700 yuan per box [4] - The overall performance of the baijiu industry is expected to stabilize, with a gradual easing of price pressures and improved market conditions post-Spring Festival [4][5] Group 4: Medical Aesthetics - The medical aesthetics market is entering a new phase, driven by innovative ingredients like recombinant collagen and PDRN, which meet the growing consumer demand for regenerative and anti-aging solutions [6] - Companies with early advantages in regulatory compliance are establishing significant barriers to entry, particularly in the emerging biocompatible materials market [6] - The market dominance of these new ingredients is expected to follow a clear hierarchy, with recombinant collagen leading the way [6]

Core Viewpoint - The financial reports from major beauty groups indicate a recovery trend in China's high-end beauty market in the second half of 2025 [1] Group 1: Financial Performance and Market Trends - L'Oréal's sales growth in mainland China is projected to be 1% in the first half and 5% in the second half of 2025, contributing to growth in the North Asia region [2] - Estée Lauder and Shiseido have adjusted their financial reporting, with Estée Lauder separating mainland China from the Asia-Pacific market starting in Q2 2025, and Shiseido merging its China and travel retail businesses [2] - Estée Lauder's revenue growth in mainland China for Q2 to Q4 of 2025 is expected to be -2%, 9%, and 13% respectively, while Shiseido's comparable sales growth is projected at -14%, -7%, 8%, and 2% for the same quarters [2] - Bain & Company's report indicates that the beauty and personal care category will be the first to recover positive growth in 2025, while other luxury categories are still in a phase of decline [2] Group 2: Consumer Behavior and Market Dynamics - Increased consumer traffic in beauty sections of malls, particularly during the pre-Spring Festival period, indicates a rise in purchasing activity [3][4] - The beauty market is expected to rebound in 2025 after a slight decline in 2024, with a projected growth rate of 5.1% [7] - High-end brands are adjusting prices and inventory to facilitate recovery, with a notable shift of consumers from high-end to mass brands due to improved offerings and competitive pricing [11][17] Group 3: Product Innovation and Market Strategy - Major beauty brands are focusing on localized research and innovation in China, with L'Oréal, Estée Lauder, and Shiseido establishing R&D centers in Shanghai [19] - New product launches and collaborations, such as L'Oréal's partnership with Huashan Hospital and Shiseido's introduction of a new medical beauty brand, reflect a trend towards localized product development [20] - The market is shifting towards more specialized segments, such as scalp care and lip care, indicating a move from basic skincare to more refined personal care [12][13] Group 4: Long-term Market Outlook - The sustainability of current growth drivers, such as price reductions and niche market expansions, remains uncertain [14] - The beauty market is entering a phase of stock competition, with brands needing to enhance core competitiveness and adapt to changing consumer preferences [18] - The demand for high-end beauty products persists, but consumers are increasingly discerning, leading to a need for brands to align pricing with product value [17]

Core Insights - The Chinese medical beauty market is experiencing a significant shift in 2025, marked by a 93.40% growth in the regenerative filling materials sector, but with notable disparities among brands [1][2] - The "Matthew Effect" is becoming evident, where leading brands are gaining market share at the expense of smaller competitors, particularly in the context of regulatory barriers and technological advancements [1][10] Regenerative Filling Materials - Regenerative filling materials have emerged as the "MVP" of the year, with a 93.40% increase in sales in 2025, continuing a trend of rapid growth over the past three years [2] - The brand "Zhenai Su Fei" under Aimeike leads with a remarkable 463% growth, while "Yiyan Shi" from Huadong Pharmaceutical, once a market leader, has seen a 56% decline [2][3] - Despite the growth of "Zhenai Su Fei," its contribution to Aimeike's overall performance remains uncertain, as the company reported over a 20% decline in revenue and net profit in the first three quarters of 2025 [2] Market Dynamics - The decline of "Yiyan Shi" is attributed to its earlier market entry leading to reduced novelty among consumers, and some users seeking alternative products after initial experiences [3] - The market for ultrasonic devices, once a star in anti-aging treatments, has seen a 55.2% drop in sales, indicating a shift in consumer preferences and budget constraints [4][8] - In contrast, the "Meila Meisheng" ultrasonic knife has gained popularity, with a 147.22% increase in sales, appealing to users aged 35 and above [4][5] Competitive Landscape - The competitive landscape is tightening, with head brands further squeezing the market space for smaller brands, as consumers tend to prefer established, reliable products [4] - The decline in ultrasonic device sales is not solely due to the emergence of new technologies but also reflects market misuse and consumer fatigue [7][10] Hyaluronic Acid Market - Hyaluronic acid remains a top-selling product, with a 19.70% increase in sales in 2025, despite facing challenges such as oversupply and intense price competition [8][9] - The product's versatility and ability to cater to a wide range of consumer needs contribute to its sustained popularity, positioning it as a mainstay in the anti-aging market [9] Future Growth Areas - The market is transitioning towards specialized segments, with a focus on individual needs and the emergence of new growth areas such as recombinant collagen products, hair loss treatments, and weight management [10][11] - The recombinant collagen market is projected to grow at a compound annual growth rate of 41.4% from 2023 to 2027, indicating strong potential for expansion [10]